Display options
Share it on

Oncoimmunology. 2014 Dec 13;3(9):e954968. doi: 10.4161/21624011.2014.954968. eCollection 2014 Oct.

New insights into androgenic immune regulation.

Oncoimmunology

Mohamed Simo Arredouani

Affiliations

  1. Department of Surgery; Beth Israel Deaconess Medical Center; Harvard Medical School ; Boston, MA USA.

PMID: 25941609 PMCID: PMC4292726 DOI: 10.4161/21624011.2014.954968

Abstract

Androgens negatively affect both central and peripheral immunity. Their potent immunosuppressive ability is thought to lead to gender dimorphism in autoimmune and infectious disease and hamper immunosurveillance of tumors. Therefore, we investigated the molecular underpinnings of androgens suppression of T-cell differentiation and found evidence that developing strategies to counteract these inhibitory effects may foster successful cancer immunotherapy in the future.

Keywords: PTPN1 phosphatase; androgens; immunosuppression; lymphocyte differentiation

References

  1. Proc Natl Acad Sci U S A. 2014 Jan 14;111(2):869-74 - PubMed
  2. Cancer Cell. 2005 Mar;7(3):239-49 - PubMed
  3. Proc Natl Acad Sci U S A. 2012 Jun 12;109(24):9505-10 - PubMed
  4. Nat Rev Immunol. 2008 Sep;8(9):737-44 - PubMed
  5. Endocrinology. 1998 Feb;139(2):748-52 - PubMed
  6. Prostate. 2009 May 1;69(6):571-84 - PubMed
  7. Prostate. 2010 Jun 15;70(9):1002-11 - PubMed
  8. Proc Natl Acad Sci U S A. 2014 Jul 8;111(27):9887-92 - PubMed
  9. J Exp Med. 2007 Feb 19;204(2):321-30 - PubMed
  10. J Neuroinflammation. 2008 Jul 31;5:32 - PubMed

Publication Types